The Skin Cancer Education and Research Foundation – Home › Forums › Immunotherapy › Side-effect management › ASCO/NCCN guidlines now out › Reply To: ASCO/NCCN guidlines now out
Rajni- you bring up two important points:
– Asymptomatic elevations of amylase and lipase may or may not be clinically significant. These labs, if drawn, must be interpreted in context; and as Lisa states, “blanket” guidelines may results in unnecessary dose holds, or worse yet, unnecessary discontinuation.
– Thanks for pointing out that colitis does not always mean diarrhea! This can be tricky for providers less experienced with the GI effects.